<DOC>
	<DOCNO>NCT00189800</DOCNO>
	<brief_summary>The purpose study ascertain clinical result solifenacin succinate PIII study conduct original country use Korean patient overactive bladder .</brief_summary>
	<brief_title>A Study Solifenacin Succinate Compared Tolterodine Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Symptoms overactive bladder Must able complete micturition diary Pregnant lactate Clinically significant outflow obstruction Significant post void residual urine Significant stress incontinence Urinary tract infection Chronic inflammation Bladder stone Previous pelvic radiation therapy Previous current malignant disease pelvic organ Uncontrolled narrow angle glaucoma Urinary gastric retention Electrostimulation therapy Bladder training Diabetic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>tolterodine</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>double-blind method</keyword>
</DOC>